Logo image of AAME

ATLANTIC AMERICAN CORP (AAME) Stock Fundamental Analysis

NASDAQ:AAME - Nasdaq - US0482091008 - Common Stock - Currency: USD

1.561  +0.03 (+2.03%)

Fundamental Rating

1

Taking everything into account, AAME scores 1 out of 10 in our fundamental rating. AAME was compared to 143 industry peers in the Insurance industry. Both the profitability and financial health of AAME have multiple concerns. AAME has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AAME had negative earnings in the past year.
AAME had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AAME reported negative net income in multiple years.
Each year in the past 5 years AAME had a positive operating cash flow.
AAME Yearly Net Income VS EBIT VS OCF VS FCFAAME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

AAME has a worse Return On Assets (-1.19%) than 86.71% of its industry peers.
AAME's Return On Equity of -4.69% is on the low side compared to the rest of the industry. AAME is outperformed by 87.41% of its industry peers.
Industry RankSector Rank
ROA -1.19%
ROE -4.69%
ROIC N/A
ROA(3y)-0.35%
ROA(5y)0.57%
ROE(3y)-1.38%
ROE(5y)1.35%
ROIC(3y)N/A
ROIC(5y)N/A
AAME Yearly ROA, ROE, ROICAAME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 6 8

1.3 Margins

AAME does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AAME Yearly Profit, Operating, Gross MarginsAAME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

More info and screens

2

2. Health

2.1 Basic Checks

AAME does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AAME remains at a similar level compared to 1 year ago.
Compared to 5 years ago, AAME has less shares outstanding
The debt/assets ratio for AAME has been reduced compared to a year ago.
AAME Yearly Shares OutstandingAAME Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
AAME Yearly Total Debt VS Total AssetsAAME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

The Debt to FCF ratio of AAME is 8.25, which is on the high side as it means it would take AAME, 8.25 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 8.25, AAME is not doing good in the industry: 72.03% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.38 indicates that AAME is not too dependend on debt financing.
The Debt to Equity ratio of AAME (0.38) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 8.25
Altman-Z N/A
ROIC/WACCN/A
WACC8.65%
AAME Yearly LT Debt VS Equity VS FCFAAME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
AAME Yearly Current Assets VS Current LiabilitesAAME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

AAME shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -570.67%.
Looking at the last year, AAME shows a small growth in Revenue. The Revenue has grown by 0.77% in the last year.
Measured over the past years, AAME shows a decrease in Revenue. The Revenue has been decreasing by -1.03% on average per year.
EPS 1Y (TTM)-570.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%113.41%
Revenue 1Y (TTM)0.77%
Revenue growth 3Y-1.94%
Revenue growth 5Y-1.03%
Sales Q2Q%4.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AAME Yearly Revenue VS EstimatesAAME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AAME. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AAME Price Earnings VS Forward Price EarningsAAME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

AAME's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AAME is cheaper than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.96
EV/EBITDA N/A
AAME Per share dataAAME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

AAME has a Yearly Dividend Yield of 1.31%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.23, AAME has a dividend in line with its industry peers.
With a Dividend Yield of 1.31, AAME pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.31%

5.2 History

The dividend of AAME has a limited annual growth rate of 0.15%.
AAME has been paying a dividend for at least 10 years, so it has a reliable track record.
AAME has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.15%
Div Incr Years0
Div Non Decr Years3
AAME Yearly Dividends per shareAAME Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 0.01 0.01 0.02

5.3 Sustainability

AAME has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-17.29%
EPS Next 2YN/A
EPS Next 3YN/A
AAME Yearly Income VS Free CF VS DividendAAME Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

More info and screens

ATLANTIC AMERICAN CORP

NASDAQ:AAME (5/2/2025, 3:47:39 PM)

1.561

+0.03 (+2.03%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)04-07 2025-04-07
Earnings (Next)05-20 2025-05-20
Inst Owners5.47%
Inst Owner Change0%
Ins Owners24.93%
Ins Owner Change0%
Market Cap31.84M
Analysts0
Price TargetN/A
Short Float %0.21%
Short Ratio0.78
Dividend
Industry RankSector Rank
Dividend Yield 1.31%
Yearly Dividend0.04
Dividend Growth(5Y)0.15%
DP-17.29%
Div Incr Years0
Div Non Decr Years3
Ex-Date04-09 2025-04-09 (0.02)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF 6.96
P/OCF 6.63
P/B 0.32
P/tB 0.33
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.22
FCFY14.37%
OCF(TTM)0.24
OCFY15.07%
SpS9.23
BVpS4.88
TBVpS4.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.19%
ROE -4.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 2.43%
ROA(3y)-0.35%
ROA(5y)0.57%
ROE(3y)-1.38%
ROE(5y)1.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 8.25
Debt/EBITDA N/A
Cap/Depr 61.48%
Cap/Sales 0.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC8.65%
ROIC/WACCN/A
Cap/Depr(3y)29.45%
Cap/Depr(5y)17.98%
Cap/Sales(3y)0.08%
Cap/Sales(5y)0.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-570.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%113.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.77%
Revenue growth 3Y-1.94%
Revenue growth 5Y-1.03%
Sales Q2Q%4.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-168.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y79.98%
FCF growth 3Y67.13%
FCF growth 5YN/A
OCF growth 1Y83.07%
OCF growth 3Y63.91%
OCF growth 5YN/A